| LSM1 |
LSM1, CASM: U6 snRNA-associated Sm-like protein LSm1 |
CORO1B |
CORO1B: Coronin-1B |
8.322 |
Evidence |
|
| PSMA7 |
PSMA7: Proteasome subunit alpha type-7 |
PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
8.322 |
Evidence |
|
| SOCS2 |
SOCS2, CIS2, SSI2, STATI2: Suppressor of cytokine signaling 2 |
CRKL |
CRKL: Crk-like protein |
8.322 |
Evidence |
|
| FADD |
FADD, MORT1: Protein FADD |
STK38 |
STK38, NDR1: Serine/threonine-protein kinase 38 |
8.317 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
8.317 |
Evidence |
|
| NMT1 |
NMT1, NMT: Glycylpeptide N-tetradecanoyltransferase 1 |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
8.317 |
Evidence |
|
| CD36 |
CD36, GP3B, GP4: Platelet glycoprotein 4 |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
8.317 |
Evidence |
|
| TAF4 |
TAF4, TAF2C, TAF2C1, TAF4A, TAFII130, TAFII135: Transcription initiation factor |
TAF1 |
IPI00149098 |
8.312 |
Evidence |
|
| H2AFX |
H2AFX, H2AX: Histone H2A.x |
HIST1H3A |
HIST1H3A, H3FA, HIST1H3B, H3FL, HIST1H3C, H3FC, HIST1H3D, H3FB, HIST1H3E, H3FD, |
8.3 |
Evidence |
|
| VAMP2 |
VAMP2, SYB2: Vesicle-associated membrane protein 2 |
STX7 |
STX7: Syntaxin-7 |
8.26 |
Evidence |
|
| PPARBP |
IPI00427522 |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
8.247 |
Evidence |
|
| TRAF2 |
TRAF2, TRAP3: TNF receptor-associated factor 2 |
CSPG6 |
SMC3, BAM, BMH, CSPG6, SMC3L1: Structural maintenance of chromosomes protein 3 |
8.247 |
Evidence |
|
| MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
PHB2 |
PHB2, BAP, REA: Prohibitin-2 |
8.247 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
GLG1 |
GLG1: Golgi apparatus protein 1 |
8.247 |
Evidence |
|
| MCM4 |
MCM4, CDC21: DNA replication licensing factor MCM4 |
PHB2 |
PHB2, BAP, REA: Prohibitin-2 |
8.247 |
Evidence |
|
| BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
RNPS1 |
RNPS1, LDC2: RNA-binding protein with serine-rich domain 1 |
8.247 |
Evidence |
|
| SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
8.247 |
Evidence |
|
| F9 |
F9: Coagulation factor IX precursor |
PSAP |
PSAP, GLBA, SAP1: Proactivator polypeptide precursor [Contains: Saposin-A |
8.23 |
Evidence |
|
| USP34 |
USP34, KIAA0570, KIAA0729: Ubiquitin carboxyl-terminal hydrolase 34 |
STAM |
STAM, STAM1: Signal transducing adapter molecule 1 |
8.222 |
Evidence |
|
| KIAA1012 |
KIAA1012: Protein TRS85 homolog |
STAM |
STAM, STAM1: Signal transducing adapter molecule 1 |
8.222 |
Evidence |
|
| RANBP9 |
RANBP9, RANBPM: Ran-binding protein 9 |
KLF13 |
KLF13, BTEB3, NSLP1: Krueppel-like factor 13 |
8.222 |
Evidence |
|
| NR5A1 |
NR5A1, AD4BP, FTZF1, SF1: Steroidogenic factor 1 |
KLF13 |
KLF13, BTEB3, NSLP1: Krueppel-like factor 13 |
8.222 |
Evidence |
|
| RELA |
RELA, NFKB3: Transcription factor p65 |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
8.222 |
Evidence |
|
| RELA |
RELA, NFKB3: Transcription factor p65 |
CAMK1 |
CAMK1: Calcium/calmodulin-dependent protein kinase type 1 |
8.222 |
Evidence |
|
| PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
PRKCQ |
PRKCQ, PRKCT: Protein kinase C theta type |
8.222 |
Evidence |
|
- 
-